New research shows diabetes medication SGLT-2 inhibitors lower dementia risk by up to 35%, offering hope for millions ...
SGLT2 inhibitors significantly improves kidney health in a diverse group of Asian adults with Type 2 diabetes, study finds.
Ozempic and Wegovy are increasingly available in Australia and worldwide to treat type 2 diabetes and obesity.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback